Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1987 Sep;92(1):105–111. doi: 10.1111/j.1476-5381.1987.tb11301.x

Effect of platelet agonists on airway reactivity and intrathoracic platelet accumulation.

D N Robertson 1, C P Page 1
PMCID: PMC1853636  PMID: 3664082

Abstract

1 Intravenous infusion of platelet activating factor (Paf), adenosine diphosphate (ADP), collagen and the thromboxane-mimetic U46619 induced a dose-related accumulation of 111indium-labelled platelets into the thoracic region of anaesthetized guinea-pigs. 2 Intravenous infusion of Paf increased the reactivity of the airways to the spasmogen histamine. Such changes were not observed following treatment with ADP, collagen or U46619. 3 Paf-induced bronchial hyperreactivity is not secondary to pulmonary platelet recruitment, changes in basal lung function or cardiovascular changes. 4 Paf-induced bronchial hyperreactivity is not dependent upon the endogenous generation of ADP or thromboxane.

Full text

PDF
105

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes P. J., Grandordy B. M., Page C. P., Rhoden K. J., Robertson D. N. The effect of platelet activating factor on pulmonary beta-adrenoceptors. Br J Pharmacol. 1987 Apr;90(4):709–715. doi: 10.1111/j.1476-5381.1987.tb11224.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Camussi G., Pawlowski I., Tetta C., Roffinello C., Alberton M., Brentjens J., Andres G. Acute lung inflammation induced in the rabbit by local instillation of 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or of native platelet-activating factor. Am J Pathol. 1983 Jul;112(1):78–88. [PMC free article] [PubMed] [Google Scholar]
  3. Capron A., Ameisen J. C., Joseph M., Auriault C., Tonnel A. B., Caen J. New functions for platelets and their pathological implications. Int Arch Allergy Appl Immunol. 1985;77(1-2):107–114. doi: 10.1159/000233762. [DOI] [PubMed] [Google Scholar]
  4. Chung K. F., Aizawa H., Leikauf G. D., Ueki I. F., Evans T. W., Nadel J. A. Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. J Pharmacol Exp Ther. 1986 Mar;236(3):580–584. [PubMed] [Google Scholar]
  5. Coleman R. A., Humphrey P. P., Kennedy I., Levy G. P., Lumley P. Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol. 1981 Jul;73(3):773–778. doi: 10.1111/j.1476-5381.1981.tb16814.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cuss F. M., Dixon C. M., Barnes P. J. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet. 1986 Jul 26;2(8500):189–192. doi: 10.1016/s0140-6736(86)92489-x. [DOI] [PubMed] [Google Scholar]
  7. Fabbri L. M. Airway inflammation and asthma. Importance of arachidonate metabolites for airway hyperresponsiveness. Prog Biochem Pharmacol. 1985;20:18–25. [PubMed] [Google Scholar]
  8. Featherstone R. L., Fosbraey P., Morton I. K. A comparison of the effects of three substance P antagonists on tachykinin-stimulated [3H]-acetylcholine release in the guinea-pig ileum. Br J Pharmacol. 1986 Jan;87(1):73–77. doi: 10.1111/j.1476-5381.1986.tb10158.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Frigas E., Gleich G. J. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol. 1986 Apr;77(4):527–537. doi: 10.1016/0091-6749(86)90341-6. [DOI] [PubMed] [Google Scholar]
  10. Hargreave F. E., Ryan G., Thomson N. C., O'Byrne P. M., Latimer K., Juniper E. F., Dolovich J. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol. 1981 Nov;68(5):347–355. doi: 10.1016/0091-6749(81)90132-9. [DOI] [PubMed] [Google Scholar]
  11. Lellouch-Tubiana A., Lefort J., Pirotzky E., Vargaftig B. B., Pfister A. Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs. Br J Exp Pathol. 1985 Jun;66(3):345–355. [PMC free article] [PubMed] [Google Scholar]
  12. Morley J., Page C. P., Paul W. Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin. Br J Pharmacol. 1983 Nov;80(3):503–509. doi: 10.1111/j.1476-5381.1983.tb10722.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Morley J., Sanjar S., Page C. P. The platelet in asthma. Lancet. 1984 Nov 17;2(8412):1142–1144. doi: 10.1016/s0140-6736(84)91567-8. [DOI] [PubMed] [Google Scholar]
  14. Page C. P., Paul W., Morley J. An in vivo model for studying platelet aggregation and disaggregation. Thromb Haemost. 1982 Jun 28;47(3):210–213. [PubMed] [Google Scholar]
  15. Persson C. G. Role of plasma exudation in asthmatic airways. Lancet. 1986 Nov 15;2(8516):1126–1129. doi: 10.1016/s0140-6736(86)90533-7. [DOI] [PubMed] [Google Scholar]
  16. Vargaftig B. B., Lefort J., Chignard M., Benveniste J. Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. Eur J Pharmacol. 1980 Jul 25;65(2-3):185–192. doi: 10.1016/0014-2999(80)90391-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES